- Aug 3, 2014
- 1,074
- 178
Thousands of people have been infected with the novel coronavirus and as experts work to learn more about the virus that hasn't been seen in humans before, more information continues to come to light.
The virus, named 2019-nCov, which causes a type of pneumonia, was first identified in Wuhan, China, in December. Since those first few cases, it's spread to more than a dozen countries, infected thousands of people, caused more than 100 deaths and prompted an international response to the outbreak.
Cases were first reported in December, but since the virus shares symptoms, such as cough, fever and shortness of breath, with many other illnesses, it's possible people were infected even months earlier. Columbia Professor of Microbiology and Immunology Vincent Racaniello told Newsweek it's possible the virus was "silently" circulating in people in October before it built up, and officials began to take notice.
www.newsweek.com
Event 201 Pandemic Exercise: Highlights Reel
Statement about nCoV and our pandemic exercise
In October 2019, the Johns Hopkins Center for Health Security hosted a pandemic tabletop exercise called Event 201with partners, the World Economic Forum and the Bill & Melinda Gates Foundation. Recently, the Center for Health Security has received questions about whether that pandemic exercise predicted the current novel coronavirus outbreak in China. To be clear, the Center for Health Security and partners did not make a prediction during our tabletop exercise. For the scenario, we modeled a fictional coronavirus pandemic, but we explicitly stated that it was not a prediction. Instead, the exercise served to highlight preparedness and response challenges that would likely arise in a very severe pandemic. We are not now predicting that the nCoV-2019 outbreak will kill 65 million people. Although our tabletop exercise included a mock novel coronavirus, the inputs we used for modeling the potential impact of that fictional virus are not similar to nCoV-2019.
Statement about nCoV and our pandemic exercise
Coronavirus
Jul 23, 2015 - THE PIRBRIGHT INSTITUTE
The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.
US Patent for Coronavirus Patent (Patent # 10,130,701 issued November 20, 2018) - Justia Patents Search
The virus, named 2019-nCov, which causes a type of pneumonia, was first identified in Wuhan, China, in December. Since those first few cases, it's spread to more than a dozen countries, infected thousands of people, caused more than 100 deaths and prompted an international response to the outbreak.
Cases were first reported in December, but since the virus shares symptoms, such as cough, fever and shortness of breath, with many other illnesses, it's possible people were infected even months earlier. Columbia Professor of Microbiology and Immunology Vincent Racaniello told Newsweek it's possible the virus was "silently" circulating in people in October before it built up, and officials began to take notice.
Latest on Novel Coronavirus: Timeline of events since the start of the outbreak in China
The novel coronavirus was first detected in people living in Wuhan, China, in December, and has since infected thousands of people.
www.newsweek.com
Event 201 Pandemic Exercise: Highlights Reel
Statement about nCoV and our pandemic exercise
In October 2019, the Johns Hopkins Center for Health Security hosted a pandemic tabletop exercise called Event 201with partners, the World Economic Forum and the Bill & Melinda Gates Foundation. Recently, the Center for Health Security has received questions about whether that pandemic exercise predicted the current novel coronavirus outbreak in China. To be clear, the Center for Health Security and partners did not make a prediction during our tabletop exercise. For the scenario, we modeled a fictional coronavirus pandemic, but we explicitly stated that it was not a prediction. Instead, the exercise served to highlight preparedness and response challenges that would likely arise in a very severe pandemic. We are not now predicting that the nCoV-2019 outbreak will kill 65 million people. Although our tabletop exercise included a mock novel coronavirus, the inputs we used for modeling the potential impact of that fictional virus are not similar to nCoV-2019.
Statement about nCoV and our pandemic exercise
Coronavirus
Jul 23, 2015 - THE PIRBRIGHT INSTITUTE
The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject.
US Patent for Coronavirus Patent (Patent # 10,130,701 issued November 20, 2018) - Justia Patents Search
